By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: IPSEN – Buy-back programme – Art 5 of MAR – Week 36 – 2025
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > Health > IPSEN – Buy-back programme – Art 5 of MAR – Week 36 – 2025
IPSEN – Buy-back programme – Art 5 of MAR – Week 36 – 2025
Health

IPSEN – Buy-back programme – Art 5 of MAR – Week 36 – 2025

GlobeNews Wire
Last updated: 09/09/2025 11:36 PM
GlobeNews Wire
Published: 09/09/2025
Share
SHARE
Aggregated presentation by day and by market

Statement of transactions in own shares from 1st September to 5th September 2025

             
Name of the issue Identity code of the issuer
(Legal Entity Identifier)
Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market         (MIC Code)
  IPSEN 549300M6SGDPB4Z94P11 01/09/2025 FR0010259150    632 116,87753 AQEU  
  IPSEN 549300M6SGDPB4Z94P11 01/09/2025 FR0010259150   1 200 116,94167 CCXE  
  IPSEN 549300M6SGDPB4Z94P11 01/09/2025 FR0010259150    200 116,90 TQEX  
  IPSEN 549300M6SGDPB4Z94P11 01/09/2025 FR0010259150   2 606 117,18388 XPAR  
  IPSEN 549300M6SGDPB4Z94P11 02/09/2025 FR0010259150    300 116,20 AQEU  
  IPSEN 549300M6SGDPB4Z94P11 02/09/2025 FR0010259150    500 116,20 CCXE  
  IPSEN 549300M6SGDPB4Z94P11 02/09/2025 FR0010259150    200 116,286 TQEX  
  IPSEN 549300M6SGDPB4Z94P11 02/09/2025 FR0010259150   3 600 116,41622 XPAR  
  IPSEN 549300M6SGDPB4Z94P11 03/09/2025 FR0010259150    300 116,70 AQEU  
  IPSEN 549300M6SGDPB4Z94P11 03/09/2025 FR0010259150    600 116,68333 CCXE  
  IPSEN 549300M6SGDPB4Z94P11 03/09/2025 FR0010259150    300 116,50967 TQEX  
  IPSEN 549300M6SGDPB4Z94P11 03/09/2025 FR0010259150   3 400 116,95335 XPAR  
  IPSEN 549300M6SGDPB4Z94P11 04/09/2025 FR0010259150   1 200 120,00 CCXE  
  IPSEN 549300M6SGDPB4Z94P11 04/09/2025 FR0010259150   3 400 119,88147 XPAR  
  IPSEN 549300M6SGDPB4Z94P11 05/09/2025 FR0010259150    300 120,00 € AQEU  
  IPSEN 549300M6SGDPB4Z94P11 05/09/2025 FR0010259150    600 120,05 CCXE  
  IPSEN 549300M6SGDPB4Z94P11 05/09/2025 FR0010259150    300 120,00 TQEX  
  IPSEN 549300M6SGDPB4Z94P11 05/09/2025 FR0010259150   3 400 119,80815 XPAR  
            23 038 118,01642    
                 
  • EN_IPSEN – Buy-back programme – Art 5 of MAR – Week 36_2025 (1)
Automechanika Shanghais 2025 fringe programme spotlights sustainability, fosters collaboration, and drives transformation
Coffee Island debuts in Delhi with its first ever 24/7 caf in GK II
Bybit Learn Upgrades Platform with Simplified Access to Crypto Education and $25,000 in Rewards
Crayola Launches First-Ever Global Color Vote, Inviting Fans Worldwide to Choose Their Favorites
U. S. Air Force Global Strike Command Reinstates the M18 Pistol
TAGGED:2025Adventureartbuy-backFR0010259150ipsenmar”newsParis:IPNPressReleaseprogrammeRegulated_Infoweek
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
SUNMI Technology (06810.HK) Officially Listed on the Main Board of HKEX
News

SUNMI Technology (06810.HK) Officially Listed on the Main Board of HKEX

08/05/2026
Artmarket.com: The Artprice Manifesto: 22 Rules for a Regulated and Transparent Art Market in the Age of AI
Mu Digital Launches “Infinite Ways to Earn” Campaign to Bootstrap Liquidity for $20T Asia Credit Market Onchain
BioNTech and DualityBios Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer
Pictor and Disease Research Limited Formalise Collaboration to Advance Johne’s Disease Monitoring Across New Zealand
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?